A comprehensive review of adverse events to drugs used in COVID-19 patients: Recent clinical evidence.

Renato Ferreira-da-Silva Inês Ribeiro-Vaz Manuela Morato Jorge Junqueira Polónia

Published in: European journal of clinical investigation (2022)

Some SOCs seem to be more frequent than others among the COVID-19 drugs included, although neither of the studies included reported causality analysis. For that purpose, further clinical studies with robust methodologies, as randomised controlled trials, should be designed and performed.

Keyphrases

sars cov
coronavirus disease
emergency department
drug induced
adverse drug